FI874596L - Peptidpreparat. - Google Patents

Peptidpreparat. Download PDF

Info

Publication number: FI874596L
Authority: FI; Finland
Prior art keywords: peptide preparations; preparations; peptide
Prior art date: 1986-10-20

Application number

FI874596A

Other languages

English (en)

Other versions

FI874596A0 (fi

FI86254C (fi

FI86254B (fi

Inventor

Klavs Holger Joergensen

Original Assignee

Novo Industri As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-10-20

Filing date

1987-10-19

Publication date

1988-04-21

1986-10-20 Priority claimed from DK503386A external-priority patent/DK503386D0/da

1987-07-10 Priority claimed from DK356987A external-priority patent/DK356987D0/da

1987-10-19 Application filed by Novo Industri As filed Critical Novo Industri As

1987-10-19 Publication of FI874596A0 publication Critical patent/FI874596A0/fi

1988-04-21 Publication of FI874596L publication Critical patent/FI874596L/fi

1992-04-30 Application granted granted Critical

1992-04-30 Publication of FI86254B publication Critical patent/FI86254B/fi

1992-08-10 Publication of FI86254C publication Critical patent/FI86254C/fi

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Diabetes (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Endocrinology (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Toxicology (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)

FI874596A 1986-10-20 1987-10-19 Foerfarande foer framstaellning av insulinpreparat. FI86254C (fi)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
DK503386		1986-10-20
DK503386A DK503386D0 (da)	1986-10-20	1986-10-20	Peptidpraeparater
DK356987		1987-07-10
DK356987A DK356987D0 (fi)	1987-07-10	1987-07-10

Publications (4)

Publication Number	Publication Date
FI874596A0 FI874596A0 (fi)	1987-10-19
FI874596L true FI874596L (fi)	1988-04-21
FI86254B FI86254B (fi)	1992-04-30
FI86254C FI86254C (fi)	1992-08-10

Family

ID=26067111

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI874596A FI86254C (fi)	1986-10-20	1987-10-19	Foerfarande foer framstaellning av insulinpreparat.

Country Status (18)

Country	Link
US (1)	US5070186A (fi)
EP (1)	EP0265213B1 (fi)
KR (1)	KR880004819A (fi)
CN (1)	CN87107049A (fi)
AU (1)	AU616381B2 (fi)
CA (1)	CA1316819C (fi)
DE (1)	DE3778287D1 (fi)
ES (1)	ES2033871T3 (fi)
FI (1)	FI86254C (fi)
GR (1)	GR3004912T3 (fi)
HU (1)	HU201475B (fi)
IE (1)	IE60264B1 (fi)
IL (1)	IL84203A (fi)
NO (1)	NO170754C (fi)
NZ (1)	NZ222214A (fi)
PH (1)	PH23446A (fi)
PT (1)	PT85949B (fi)
YU (1)	YU46665B (fi)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5534488A (en) *	1993-08-13	1996-07-09	Eli Lilly And Company	Insulin formulation
YU18596A (sh) *	1995-03-31	1998-07-10	Eli Lilly And Company	Analogne formulacije monomernog insulina
EP1044016B1 (en) *	1998-01-09	2005-03-16	Novo Nordisk A/S	Stabilised insulin compositions
US7678364B2 (en)	1999-08-25	2010-03-16	Alkermes, Inc.	Particles for inhalation having sustained release properties
DE10114178A1 (de) *	2001-03-23	2002-10-10	Aventis Pharma Gmbh	Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
ATE333260T1 (de) *	2001-08-27	2006-08-15	Novo Nordisk As	Eine patrone und ein medizinisches anlieferungssystem das solch eine patrone unterbringt
CA2512052C (en) *	2002-12-31	2016-06-21	Altus Pharmaceuticals Inc.	Human growth hormone crystals and methods for preparing them
ZA200505306B (en) *	2002-12-31	2006-09-27	Altus Pharmaceuticals Inc	Complexes of protein crystals and ionic polymers
US20090023629A1 (en) *	2005-12-23	2009-01-22	Altus Pharmaceuticals Inc.	Compositions comprising polycation-complexed protein crystals and methods of treatment using them
WO2008015099A2 (en)	2006-07-31	2008-02-07	Novo Nordisk A/S	Pegylated, extended insulins
JP5864834B2 (ja)	2006-09-22	2016-02-17	ノボ・ノルデイスク・エー／エス	プロテアーゼ耐性のインスリンアナログ
WO2008132229A2 (en) *	2007-04-30	2008-11-06	Novo Nordisk A/S	Highly concentrated insulin solutions and compositions
ES2563038T3 (es)	2007-04-30	2016-03-10	Novo Nordisk A/S	Método para secar una composición proteica, una composición proteica seca y una composición farmacéutica que comprende la proteína seca
CN101970477B (zh)	2008-03-14	2014-12-31	诺沃-诺迪斯克有限公司	蛋白酶稳定的胰岛素类似物
JP5749155B2 (ja)	2008-03-18	2015-07-15	ノボ・ノルデイスク・エー／エス	プロテアーゼ安定化アシル化インスリンアナログ
PT2349324T (pt)	2008-10-17	2017-12-06	Sanofi Aventis Deutschland	Combinação de uma insulina e de um agonista do glp-1
WO2011058083A1 (de)	2009-11-13	2011-05-19	Sanofi-Aventis Deutschland Gmbh	Pharmazeutische zusammensetzung umfassend einen glp-1-agonisten, ein insulin und methionin
SG10201500871TA (en)	2009-11-13	2015-04-29	Sanofi Aventis Deutschland	Pharmaceutical composition comprising a glp-1 agonist and methionine
CN101912600B (zh) *	2010-01-11	2014-01-29	杨国汉	改善胰岛素在溶液中稳定性的方法
US8637458B2 (en) *	2010-05-12	2014-01-28	Biodel Inc.	Insulin with a stable basal release profile
AU2011202239C1 (en)	2010-05-19	2017-03-16	Sanofi	Long-acting formulations of insulins
RS55378B1 (sr)	2010-08-30	2017-03-31	Sanofi Aventis Deutschland	Upotreba ave0010 za proizvodnju leka za tretman diabetes mellitus tipa 2
US9821032B2 (en)	2011-05-13	2017-11-21	Sanofi-Aventis Deutschland Gmbh	Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
HRP20151068T1 (hr)	2011-08-29	2016-01-01	Sanofi-Aventis Deutschland Gmbh	Farmaceutska kombinacija za upotrebu za glikemijsku kontrolu kod pacijenata s dijabetesom tipa 2
AR087744A1 (es)	2011-09-01	2014-04-16	Sanofi Aventis Deutschland	Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
BR112014025132A2 (pt)	2012-04-11	2017-07-11	Novo Nordisk As	formulações de insulina
US9399065B2 (en)	2012-04-16	2016-07-26	Biodel Inc.	Magnesium compositions for modulating the pharmacokinetics and injection site pain of insulin
US9381247B2 (en) *	2012-04-16	2016-07-05	Biodel Inc.	Magnesium compositions for modulating the pharmacokinetics and pharmacodynamics of insulin and insulin analogs, and injection site pain
AU2014247167B2 (en)	2013-04-03	2018-11-22	Sanofi	Treatment of diabetes mellitus by long–acting formulations of insulins
ES2676065T3 (es)	2013-10-07	2018-07-16	Novo Nordisk A/S	Nuevo derivado de un análogo de la insulina
TWI758239B (zh)	2014-12-12	2022-03-21	德商賽諾菲阿凡提斯德意志有限公司	甘精胰島素/利司那肽固定比率配製劑
TWI748945B (zh)	2015-03-13	2021-12-11	德商賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患治療
TW201705975A (zh)	2015-03-18	2017-02-16	賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患之治療
HUE060149T2 (hu)	2016-12-16	2023-02-28	Novo Nordisk As	Inzulint tartalmazó gyógyászati készítmények

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2076082A (en) *	1935-04-08	1937-04-06	Nordisk Insulinlab	Therapeutic product and process
US2179384A (en) *	1937-04-05	1939-11-07	Univ Alberta	Therapeutic composition and process of making it
US2190134A (en) *	1939-06-09	1940-02-13	Norton Co	Grinding machine
US2538018A (en) *	1944-04-04	1951-01-16	Nordisk Insulinlab	Crystalline product of insulin and alkaline protein and process of making it
US2474729A (en) *	1945-01-03	1949-06-28	Rhone Poulenc Sa	Insulin preparations
US2801953A (en) *	1952-02-28	1957-08-06	Hoechst Ag	Process of preparing crystallized insulin preparations
US3102077A (en) *	1953-08-19	1963-08-27	Christensen Henry Marinus	Preparation of insulin containing 2.75 to 8 percent zinc content
DK98342C (da) *	1959-06-16	1964-03-31	Henry Marinus Dr Christensen	Fremgangsmåde til fremstilling af et insulinpræparat til peroral applikation.
US3868358A (en) *	1971-04-30	1975-02-25	Lilly Co Eli	Protamine-insulin product
GB1426061A (en) *	1972-12-28	1976-02-25	Ici Ltd	Polypeptides
US3856771A (en) *	1973-07-16	1974-12-24	Lilly Co Eli	Process for manufacturing alkali metal or ammonium insulin
US4196196A (en) *	1978-06-19	1980-04-01	Tiholiz Ivan C	Divalen/monovalent bipolar cation therapy for enhancement of tissue perfusion and reperfusion in disease states
AU550068B2 (en) *	1981-03-10	1986-02-27	Novo Nordisk A/S	Zinc insulin stabilized with calcium or magnesium salts
US4839341A (en) *	1984-05-29	1989-06-13	Eli Lilly And Company	Stabilized insulin formulations
US4764592A (en) *	1987-04-23	1988-08-16	Eli Lilly And Company	Crystalline human proinsulin and process for its production

1987
- 1987-10-14 PH PH35937A patent/PH23446A/en unknown
- 1987-10-19 AU AU79907/87A patent/AU616381B2/en not_active Ceased
- 1987-10-19 ES ES198787309229T patent/ES2033871T3/es not_active Expired - Lifetime
- 1987-10-19 YU YU191887A patent/YU46665B/sh unknown
- 1987-10-19 FI FI874596A patent/FI86254C/fi not_active IP Right Cessation
- 1987-10-19 PT PT85949A patent/PT85949B/pt unknown
- 1987-10-19 IE IE279987A patent/IE60264B1/en not_active IP Right Cessation
- 1987-10-19 HU HU874683A patent/HU201475B/hu not_active IP Right Cessation
- 1987-10-19 DE DE8787309229T patent/DE3778287D1/de not_active Expired - Lifetime
- 1987-10-19 NZ NZ222214A patent/NZ222214A/xx unknown
- 1987-10-19 IL IL84203A patent/IL84203A/xx not_active IP Right Cessation
- 1987-10-19 NO NO874347A patent/NO170754C/no unknown
- 1987-10-19 EP EP87309229A patent/EP0265213B1/en not_active Expired - Lifetime
- 1987-10-20 KR KR870011644A patent/KR880004819A/ko not_active Ceased
- 1987-10-20 CN CN198787107049A patent/CN87107049A/zh not_active Withdrawn
- 1987-10-20 CA CA000549713A patent/CA1316819C/en not_active Expired - Fee Related
1989
- 1989-04-19 US US07/340,331 patent/US5070186A/en not_active Expired - Fee Related
1992
- 1992-06-11 GR GR920401262T patent/GR3004912T3/el unknown

Also Published As

Publication number	Publication date
GR3004912T3 (fi)	1993-04-28
IE60264B1 (en)	1994-06-29
US5070186A (en)	1991-12-03
AU7990787A (en)	1988-04-21
YU46665B (sh)	1994-01-20
AU616381B2 (en)	1991-10-31
KR880004819A (ko)	1988-06-27
DE3778287D1 (de)	1992-05-21
NO874347D0 (no)	1987-10-19
NZ222214A (en)	1989-11-28
IL84203A (en)	1993-04-04
FI874596A0 (fi)	1987-10-19
FI86254C (fi)	1992-08-10
FI86254B (fi)	1992-04-30
NO170754C (no)	1992-12-02
PT85949B (pt)	1990-07-31
ES2033871T3 (es)	1993-04-01
PH23446A (en)	1989-08-07
EP0265213A2 (en)	1988-04-27
HU201475B (en)	1990-11-28
NO170754B (no)	1992-08-24
CA1316819C (en)	1993-04-27
NO874347L (no)	1988-04-21
CN87107049A (zh)	1988-07-06
HUT46232A (en)	1988-10-28
IE872799L (en)	1988-04-20
EP0265213B1 (en)	1992-04-15
PT85949A (en)	1987-11-01
EP0265213A3 (en)	1988-11-09
YU191887A (en)	1989-04-30

Publication	Publication Date	Title
FI874596L (fi)	1988-04-21	Peptidpreparat.
FI874495L (fi)	1988-04-14	Peptidderivat.
FI873185A7 (fi)	1988-01-22	Uusia peptidejä.
FI873570L (fi)	1987-08-18	Peptidpreparat, foerfarande foer framstaellning av detta och anvaendning av detta.
FI860096L (fi)	1986-07-13	Haorfaergmedels-preparat.
DE3789413D1 (de)	1994-04-28	Lymphokin-ähnliche Peptide.
DE3774374D1 (de)	1991-12-12	Wundheilende zubereitungen.
NO881384L (no)	1988-10-03	Peptider.
NO890453D0 (no)	1989-02-03	Artropodicide preparater.
NO885108D0 (no)	1988-11-16	Peptider.
FI883257A7 (fi)	1988-07-07	Uudet peptidit.
DK354487A (da)	1988-01-12	Oncogen-relaterede peptider
FI874382A7 (fi)	1988-04-08	Farmaseuttiset valmisteet.
FI861193L (fi)	1986-09-26	Stabilt gammainterferonpreparat.
FI882921L (fi)	1988-06-17	Protaminzink-insulinpreparat.
NO875019D0 (no)	1987-12-02	Antikariogene preparater.
FI874587A0 (fi)	1987-10-19	Renande av protein.
FI864626L (fi)	1987-09-08	Rekombinantricintoxin.
FI881519L (fi)	1988-10-02	Schampopreparat.
DE3780388D1 (de)	1992-08-20	Fsh-stimulierendes peptid.
DK503386D0 (da)	1986-10-20	Peptidpraeparater
NO911243L (no)	1991-05-23	Kjemiske preparater.
DE3685636D1 (de)	1992-07-16	Lysozymbetreffende peptide.
NO872386D0 (no)	1987-06-05	Peptider.
FI875151A7 (fi)	1987-11-20	Uudet peptidijohdannaiset.

Legal Events

Date	Code	Title	Description
1996-05-17	MM	Patent lapsed
2004-08-31	MM	Patent lapsed	Owner name: NOVO NORDISK A/S